The nation of Zimbabwe has turned down a substantial American health deal worth 367 million US dollars (£272m) over five years over the United States' request for sensitive information.
This move was revealed following a official document dated December was disclosed, which showed President Emmerson Mnangagwa believed the agreement was "unbalanced".
An official spokesman has since stated that the United States was requesting genetic material for research and commercial purposes but refused to share the resulting advantages from future treatments.
"We are forced to start the challenging and unfortunate process of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had furnished over $1.9bn as health assistance to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has appealed for continued dialogue to secure a deal suitable to all parties so the country's critical HIV treatment initiative can be sustained.
Broader Context
Zimbabwe's decision follows a comparable case in Kenya, where a court halted a similar deal with the US after legal challenges were filed about the safety of Kenyans' medical information.
Since resuming the presidency recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
USAID had overseen aid for the American government, but Trump argued its spending was "wasteful" and his government was pursuing direct bilateral agreements to enhance transparency and accountability.
As per reports, Sixteen African countries have so far signed these new agreements, constituting more than $18.3bn in new funding.
Details of the Rejected Deal
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership could have provided immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving HIV treatment via US-supported programmes," Tremont added.
However, official spokesman Nick Mangwana said the arrangement was "unfair".
"Zimbabwe was being asked to provide its genetic material and health information over an extended period, with no corresponding assurance of access to any medical innovations – such as new medicines or tests – that might be developed from that provided information," his statement read.
"Effectively, our nation would provide the basic resources for scientific discovery with no assurance that the final treatments would be available to our people if a new health crisis emerge."
National Interest and International Frameworks
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining frameworks already established through the international organization.
The spokesperson cited its Pandemic Benefit-Sharing scheme designed to deal with future global health emergencies.
"This framework is designed to guarantee that when a nation provides its information, the benefits – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the resources to create them."
These objections regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We encourage continued discussions with our American counterparts on how future collaboration could be structured in a manner that respects the sovereignty and dignity of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but suggested that talks must proceed considering much of the country's Aids initiatives relied on international support.
"Where specific concerns arise, such as those relating to data governance or implementation frameworks, these can frequently be addressed via detailed discussion and mutually agreed protections," the group said.
The situation underscores the continuing debate between accepting vital foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.